Company intelligence / Profile preview

Riyadh Pharma

Riyadh, Ar Riyad, Saudi Arabia

Ownership: Private
Employees: ~129
Development stage: Other

Overview

Riyadh Pharma is one of the leading pharmaceutical manufacturers in Saudi Arabia, producing over 100 generic and branded drugs at commercial scale. Products are sold locally and registered in several Arab countries; the company is pursuing registrations in Europe and the US. No specific details are available on clinical pipeline or recent clinical results, as most output comprises generic and branded finished products.[1][2][3][4]

Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Partnership with government and educational institutions in Saudi Arabia[1]

Beyond the preview

Go deeper on Riyadh Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Riyadh Pharma.

Explore the full profile